share_log

Insiders Have Been Selling YSB Inc. (HKG:9885) Recently yet Still Hold a Significant Stake; 12% Drop Last Week Not Ideal

Insiders Have Been Selling YSB Inc. (HKG:9885) Recently yet Still Hold a Significant Stake; 12% Drop Last Week Not Ideal

內部人士最近在出售藥師幫(HKG:9885)的股票,但仍持有顯著股份;上週下跌12%並不理想
Simply Wall St ·  12/11 06:19

Key Insights

關鍵洞察

  • Insiders appear to have a vested interest in YSB's growth, as seen by their sizeable ownership
  • 56% of the business is held by the top 5 shareholders
  • Insiders have sold recently
  • 內部人士似乎對藥師幫的增長有既得利益,因爲他們擁有大量股份
  • 56%的業務由前五大股東持有
  • 內部人士最近出售了股票。

If you want to know who really controls YSB Inc. (HKG:9885), then you'll have to look at the makeup of its share registry. The group holding the most number of shares in the company, around 28% to be precise, is individual insiders. In other words, the group stands to gain the most (or lose the most) from their investment into the company.

如果你想知道誰真正控制了YSb Inc. (HKG:9885),那麼你需要查看其股權登記冊的組成。持有公司最多股份的群體,大約佔28%,實際上是個人內部人士。換句話說,這個群體從對公司的投資中獲益最多(或損失最多)。

And our data suggests that insiders own the top position in the company's share registry despite recent sales. As market cap fell to HK$3.7b last week, they would have faced the highest losses than any other shareholder groups of the company.

我們的數據顯示,儘管最近有出售,內部人士仍然擁有公司股東名冊的最高位置。上週市值降至37億港元時,他們面臨的損失將比任何其他股東群體都要高。

In the chart below, we zoom in on the different ownership groups of YSB.

在下圖中,我們關注YSB不同的所有權群體。

big
SEHK:9885 Ownership Breakdown December 10th 2024
SEHK:9885 所有權分解 2024年12月10日

What Does The Institutional Ownership Tell Us About YSB?

機構所有權給我們提供了關於YSB什麼信息?

Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.

許多機構的表現與近似當地市場的指數進行比較。因此,他們通常更加關注那些被納入主要指數的公司。

As you can see, institutional investors have a fair amount of stake in YSB. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see YSB's historic earnings and revenue below, but keep in mind there's always more to the story.

正如你所看到的,機構投資者在YSB擁有相當數量的股份。這在專業投資者中增強了一定的可信度。但我們不能僅僅依靠這一點,因爲機構有時也會做出錯誤的投資,就像其他人一樣。當多家機構同時擁有一隻股票時,風險總是存在它們處於「擁擠交易」中。當這樣的交易出現問題時,多個參與者可能會爭相快速賣出股票。在沒有增長曆史的公司中,這種風險更高。你可以在下面看到YSB的歷史收益和營業收入,但請記住,事情總是有更多的故事。

big
SEHK:9885 Earnings and Revenue Growth December 10th 2024
SEHK:9885 2024年12月10日的盈利和收入增長

Our data indicates that hedge funds own 12% of YSB. That worth noting, since hedge funds are often quite active investors, who may try to influence management. Many want to see value creation (and a higher share price) in the short term or medium term. The company's CEO Buzhen Zhang is the largest shareholder with 19% of shares outstanding. Tiger Global Management, LLC is the second largest shareholder owning 12% of common stock, and Mang Yee Chu holds about 9.4% of the company stock.

我們的數據表明對沖基金擁有藥師幫12%的股份。這值得注意,因爲對沖基金通常是相當活躍的投資者,可能會試圖影響管理層。許多人希望在短期或中期看到價值創造(和更高的股價)。公司的首席執行官張步真是最大的股東,持有19%的流通股份。泰虎全球管理公司是第二大股東,擁有12%的普通股,朱孟毅持有約9.4%的公司股票。

Our research also brought to light the fact that roughly 56% of the company is controlled by the top 5 shareholders suggesting that these owners wield significant influence on the business.

我們的研究還揭示了一個事實,即公司約56%的股份由前5大股東控制,這表明這些所有者對業務有顯著的影響力。

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. We're not picking up on any analyst coverage of the stock at the moment, so the company is unlikely to be widely held.

研究機構持股是一種衡量和篩選股票預期表現的好方法。通過研究分析師的情緒也可以達到相同的目的。 目前我們沒有注意到該股票的分析師覆蓋,因此該公司不太可能被廣泛持有。

Insider Ownership Of YSB

藥師幫的內部持股情況

While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. The company management answer to the board and the latter should represent the interests of shareholders. Notably, sometimes top-level managers are on the board themselves.

儘管內部人的確切定義可能是主觀的,但幾乎所有人都認爲董事會成員是內部人。公司管理層對董事會負責,而後者應代表股東的利益。值得注意的是,有時高層管理人員自己也在董事會中。

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

我通常認爲內部人擁有股份是一件好事。然而,在某些情況下,這使得其他股東更難讓董事會對決策負責。

It seems insiders own a significant proportion of YSB Inc.. Insiders have a HK$1.0b stake in this HK$3.7b business. It is great to see insiders so invested in the business. It might be worth checking if those insiders have been buying recently.

看起來內部人士擁有藥師幫公司的很大一部分股份。內部人士在這個37億港元的業務中持有10億港元的股份。看到內部人士如此投入於業務真是太好了。可能值得檢查一下這些內部人士是否最近在買入。

General Public Ownership

公衆持股

The general public-- including retail investors -- own 26% stake in the company, and hence can't easily be ignored. While this size of ownership may not be enough to sway a policy decision in their favour, they can still make a collective impact on company policies.

公衆,包括散戶投資者,擁有該公司26%的股份,因此無法輕易忽視。雖然這種股份的規模可能不足以左右政策的決策,但他們仍然可以對公司政策產生集體影響。

Private Equity Ownership

股權投資公司持有8.8%的股份,有能力參與塑造以價值創造爲重點的公司策略。一些投資者可能會因此而受到鼓舞,因爲股權投資公司有時可以鼓勵市場看到公司的價值,從而採取有益的策略。另外,那些持有者可能在將其上市後退出投資。

Private equity firms hold a 16% stake in YSB. This suggests they can be influential in key policy decisions. Some investors might be encouraged by this, since private equity are sometimes able to encourage strategies that help the market see the value in the company. Alternatively, those holders might be exiting the investment after taking it public.

股權投資公司持有藥師幫16%的股份。這表明他們在關鍵政策決策中可能具有影響力。一些投資者可能會因此感到鼓舞,因爲股權投資有時能夠推動策略,幫助市場看到公司的價值。另一方面,這些持有者可能在公司上市後退出投資。

Private Company Ownership

私有公司所有權

Our data indicates that Private Companies hold 3.1%, of the company's shares. Private companies may be related parties. Sometimes insiders have an interest in a public company through a holding in a private company, rather than in their own capacity as an individual. While it's hard to draw any broad stroke conclusions, it is worth noting as an area for further research.

我們的數據顯示,私營公司持有公司3.1%的股份。私營公司可能是關聯方。有時內部人士通過在私營公司中的持股,而不是作爲個人出現在公衆公司中。雖然很難得出任何廣泛的結論,但值得注意的是這是一個進一步研究的領域。

Public Company Ownership

上市公司所有權

We can see that public companies hold 5.9% of the YSB shares on issue. This may be a strategic interest and the two companies may have related business interests. It could be that they have de-merged. This holding is probably worth investigating further.

我們可以看到,上市公司持有藥師幫已發行股份的5.9%。這可能是一個戰略性利益,兩個公司之間可能存在相關的商業利益。他們可能已經進行過拆分。這一持股可能值得進一步調查。

Next Steps:

下一步:

It's always worth thinking about the different groups who own shares in a company. But to understand YSB better, we need to consider many other factors. Consider risks, for instance. Every company has them, and we've spotted 3 warning signs for YSB you should know about.

考慮到擁有公司股份的不同群體總是值得的。但要更好地了解藥師幫,我們需要考慮許多其他因素。 例如,考慮風險。每家公司都有風險,我們發現藥師幫有3個你應該知道的警告信號。

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

當然,您也可能會在其他地方找到一個絕佳的投資。請查看這個免費的有趣公司名單。

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

注意:本文中的數字是根據過去十二個月的數據計算得出的,指的是截至財務報表日期的月份最後一天的12個月期間。這可能與完整年度的年報數字不一致。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall St的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall St在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論